Uptake and Transfection with Polymeric Nanoparticles Are Dependent on Polymer End-Group Structure, but Largely Independent of Nanoparticle Physical and Chemical Properties

Purpose: Non-viral gene delivery requires a better understanding of which polymer properties enable nanoparticles to overcome intracellular barriers. Poly(beta-amino ester)s (PBAEs) are promising, but the mechanisms behind their effectiveness—especially the roles of buffering capacity, degradation rate, and end-group structure—had not been fully quantified.

Hypothesis: If small structural changes are made along the backbone, side chain, and end group of linear PBAEs, then polymer buffering capacity, degradation rate, nanoparticle uptake, and transfection efficacy will vary. End-group modification with amine-containing small molecules will be critical for cellular uptake and transfection, largely independent of nanoparticle size, zeta potential, and DNA binding.

Aims: Synthesize an array of linear PBAEs with single-carbon changes in backbone, side chain, and end group. - Characterize nanoparticle size, zeta potential, DNA retardation, buffering capacity, and degradation rate. - Quantify cellular uptake, transfection efficacy, and cytotoxicity in COS-7 cells. - Correlate polymer properties with biological outcomes. - Compare PBAEs with 25 kDa branched polyethylenimine (PEI).

Approach: In vitro only. No in vivo animal studies. - Cell line: COS-7 (monkey kidney fibroblasts). - Transfection: 96-well plates; 15,000 cells/well; 600 ng pDNA/well; 4 h incubation; analysis 48 h post-transfection. - Uptake: Cy3-labeled pDNA; flow cytometry 4 h post-transfection. - Viability: MTS assay 24 h post-transfection. - Controls: Untreated cells; 25 kDa branched PEI/DNA at 3:1 w/w. - Replicates: Quadruplicate; mean ± SD. - Statistics: One-way ANOVA with Bonferroni post-tests; p < 0.05 considered significant.

Key methods: Polymer characterization: ¹H NMR; gel permeation chromatography (GPC). - Nanoparticle characterization: Dynamic light scattering (DLS); nanoparticle tracking analysis (NTA); zeta potential. - DNA binding: Agarose gel electrophoresis with and without bromophenol blue. - Buffering capacity: Acid-base titration from pH 3 to 11; buffering calculated per amine and per mass between pH 7.4 and 5.1. - Degradation: GPC in PBS at 37 °C; half-life determination. - Uptake/transfection/viability: Flow cytometry (GFP and Cy3) and MTS assay.

Key results: Nanoparticle properties: All polymers formed positively charged nanoparticles (~130–150 nm; zeta +21 to +29 mV). Size and zeta potential were not strongly correlated with uptake or transfection. - Buffering capacity: PBAEs buffered 1.4–4.6 mmol H⁺/g and 34–95% of amines over pH 5.1–7.4. PEI buffered 6.2 mmol H⁺/g. Because PBAEs are less cytotoxic, they can be used at much higher w/w ratios (60 w/w vs 1–3 w/w for PEI), giving higher total buffering capacity per formulation. - Degradation: PBAE half-lives in PBS at 37 °C ranged from 90 min to ~6 h. Rapid degradation may reduce cytotoxicity but could also limit DNA protection. - Uptake and transfection: Uptake ranged from 0% to 95%; transfection ranged from 0% to 93% depending on structure. Five polymers achieved higher uptake and transfection than PEI with less toxicity. - Acrylate vs end-capped: Acrylate-terminated base polymers had dramatically lower uptake (1–3%) and transfection (0–1%) than amine end-capped versions (uptake 75–94%; transfection 20–89%), despite minimal differences in DNA retardation, particle size, zeta potential, and cytotoxicity. - End-group effect: E7 end-capping generally gave highest buffering; E6 and E4 gave lower buffering. B4-S4-E7 1.1:1 had highest transfection/uptake but also highest toxicity among the B4-S4-E7 molecular weight variants.

Interpretation: The authors claim that small-molecule end-group modification of linear PBAEs is critical for cellular uptake and transfection, and that this effect is largely independent of polymer/DNA binding, particle size, and particle surface charge. PBAEs buffer fewer protons per mass than PEI, but because they are less cytotoxic they can be formulated at much higher polymer:DNA ratios, giving greater total buffering capacity per particle formulation. The study helps elucidate structure–function relationships for non-viral gene delivery and highlights end-group chemistry as a key design parameter.

Limitations: In vitro only: No in vivo validation, biodistribution, or therapeutic efficacy. - Single cell line: COS-7 cells only; generalizability to primary or human disease-relevant cells not established. - No direct mechanistic proof: Endosomal escape and intracellular trafficking were not directly visualized; buffering and degradation are inferred from physicochemical assays. - Correlation, not causation: Structure–function relationships are correlative; the exact mechanism by which end groups enhance uptake remains unresolved. - Toxicity: Some lead polymers showed increased cytotoxicity; therapeutic window not fully defined. - No targeting ligand: Delivery relies on nonspecific electrostatic interactions. - No long-term expression or safety data. - No comparison with viral vectors. - Citation details incomplete in supplied file: DOI and exact journal citation were not present in the supplied excerpt.